Las Vegas—It is far from easy to predict which patients with hepatitis C virus (HCV) infection will adhere to therapy and rid themselves of that potentially devastating chronic liver disease. But at Johns Hopkins Medicine, clinical specialty pharmacists and nurses use a triage method to boost adherence rates as well as the odds of successful outcomes.
They call it the “stoplight” protocol. Before any costly specialty drug is ordered, patients presenting to the